Source link : https://newshealth.biz/health-news/cancer-drug-pulled-from-the-market-regains-fda-approval/
(MedPage Today) — The FDA has once again approved belantamab mafodotin (Blenrep) for multiple myeloma, 3 years after the drug left the market over questions about its efficacy. A B-cell maturation antigen (BCMA)-targeted drug, belantamab mafodotin… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/118122 Author : Publish date : 2025-10-23 21:45:00 Copyright for syndicated content belongs to the linked […]
The post Cancer Drug Pulled From the Market Regains FDA Approval first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-23 21:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8